Search headlines

Bellevue startup Temporal sees valuation jump to $12.6 billion with latest funding round

Temporal, the Bellevue app development startup, raised $550 million at a $12.55 billion valuation, doubling its worth since February.

Sep 14 • 5:11 PM EDT • Business • bizjournals.com

PENN Entertainment: Not Much To Get Excited About

PENN Entertainment remains a Hold with an $18 price target due to mixed earnings and limited valuation upside versus peers. Learn more about PENN stock here.

Sep 14 • 3:26 AM EDT • Entertainment • seekingalpha.com

PENN Entertainment holds steady with $18 target amid mixed earnings and debt concerns.

PENN Entertainment maintains a Hold rating with an $18 price target due to mixed Q2 earnings and limited valuation upside compared to peers. The retail segment showed solid growth with a 5.6% increase in adjusted EBITDAR, especially strong in the Midwest and West regions. However, the Interactive segment's revenue growth has slowed sharply despite improving profitability, raising concerns about long-term competitiveness. The company remains highly leveraged with net debt around 5.2x–5.5x, making proactive debt reduction and consistent Interactive profitability key factors to watch going forward.

Sep 13 • 8:00 PM EDT • Entertainment • pluang.com

Clover Health (CLOV) Stock Looks Fairly Priced Despite Profit Turnaround

Clover Health Investments has staged a very strong three year run, yet the current checks still suggest the stock leans cheap rather than fully pricing in that shift in fortunes. The share price has returned about 3.3x over three years, which puts recent trading firmly in the high move bracket for this period. Profitability progress and Medicare Advantage membership growth can support the case for the current valuation, while higher medical costs and healthcare usage remain a clear risk to...

Sep 13 • 3:19 AM EDT • Health • simplywall.st

Hinge Health (HNGE) Stock Looks Overvalued On Earnings But Mixed On Broader Checks

Hinge Health stock has nearly doubled year to date, yet the latest valuation checks point to a company that screens as overvalued on market multiples and only delivers a mixed overall value score. For anyone tracking the recent rally, the question is whether the current price already bakes in most of the optimism around the business. Hinge Health is up 94.4% year to date, which puts recent buyers on notice that expectations embedded in the share price have moved a long way in a short...

Sep 12 • 10:18 PM EDT • Health • simplywall.st

Meant Health Expands Telehealth Access to FDA-Approved GLP-1 Prescriptions, Including Ozempic®

Meant Health, a digital health platform that connects patients with licensed clinicians for evaluation, prescription and ongoing care coaching, announced today that it is expanding telehealth access to FDA-approved GLP-1 medications. The move is meant to shorten the distance between someone wondering whether a treatment might be right for them and an actual conversation with a U.S.-licensed clinician who could review their history and make that call.

Sep 12 • 7:00 AM EDT • Health • finance.yahoo.com

The politics and possibilities of ‘AI could kill us all’

I found myself fielding a lot of questions from folks who don’t usually talk much about AI this week. They were mostly along the lines of “do you think AI is going to kill us all?” or “how worried should I be about this human extinction stuff?” Motivating this wave of existential anxiety was the highly dramatic resignation of now-former Anthropic employee Jacob Coxon, who quit his job while publicly sharing his concerns about safety practices at the leading AI companies. More specifically, he declared that almost everyone at OpenAI and Anthropic, the leading AI labs, believes that there’s a decent chance the AI systems they’re producing could “kill us all” by the end of the decade, and the companies aren’t “acting responsibly.” Other AI safety researchers, including those still employed at Anthropic and OpenAI, all confirmed that yes, Coxon is correct, they’re all worried that their company’s products might prove fatal for the entire human race as well. Two more AI employees quit and joined the chorus. Now, the warning shot has been covered everywhere from the Wall Street Journal to Fox News to WIRED to the Guardian. I understand why all this sounds scary, but my response to those who have asked, has generally been: No, you don’t need to worry that AI will kill go rogue and kill us all. But that does not mean we shouldn’t worry, period. Far from it. The companies building AI products are now among the wealthiest and most powerful entities in the world. And they very much are building enormous engines of mass surveillance, extraction, and automation. They can and have allowed their AI systems to carry out felony hacks of other companies, provided the government with autonomously generated kill lists, and sold enterprise technology to firms around the world that is explicitly intended to replace jobs. But “AI” has done these things not because they have all-powerful minds of their own but, ultimately, because people have programmed, calibrated, and directed them to. In other words, it’s not AI we need to worry the most about. It’s the people and corporations working to profit from and gain power by deploying it. The technology is sophisticated, sure, and, especially in cybersecurity contexts, potentially disruptive to plenty of existing systems. But if we want to stop this predatory, profiteering, and extractive form of AI—and it’s worth noting that at this point, most people do—we absolutely can. A quick note/plea: I can only do all of this with the support of readers like you, so if you find value in independent, critical tech journalism and analysis, please consider becoming a paid subscriber. I want to keep as much of this un-paywalled as absolutely possible, and I need your support to do so. Many thanks to all who continue to chip in, it’s very much appreciated. Onward. Subscribe First, some context: AI industry folks like Coxon have been discussing the prospect that AI will destroy humanity for years. Even before the beginning of the AI boom, many working in the industry, from the executive staff to the rank and file researchers, have obsessed over ‘x-risk’, or the possibility that AI will become sentient or semi-sentient and move one way or another to exterminate humanity. This is ostensibly why Elon Musk bankrolled OpenAI in the first place, and is the grounds for his lawsuit alleging OpenAI betrayed its charter by abandoning its nonprofit status to become a commercial enterprise. Many AI engineers and startup founders have calculated their own personal p(doom), or the probability that the tech product they are working on will initiate an actual humanity-extinguishing apocalypse. 10-25% p(doom)s are pretty common. (I wrote about a long weekend I spent among these folks at one of their top conferences here, to give you an idea of their ideas and belief systems.) Sam Altman himself drove the narrative of the imminent rise of a super-powerful AI, or artificial general intelligence, to prominence by declaring that the technology he was building posed an existential risk to humanity. This idea is in other words baked into the DNA of modern AI companies and into the products they engineer. It’s also why the industry is routinely accused, by myself and others, of “doom marketing,” ie, using such proclamations and framings to impart the sheer power of the technology behind your product onto investors, partners, consumers, and the state. Some ambient understanding of this tendency may have helped prevent the press from repeating the claim every time one of the x-risk folks made it over the years, including when they quit their jobs at AI companies while doing so. Yet Coxon’s AI x-risk alarm has broken containment, as they say, and has exposed the idea to the mainstream media once again. This has happened, I think, for a number of reasons. First, when AI CEOs were going around saying AI might kill everyone in 2023, their companies were well-capitalized, but not nearly to the extent they are today. They were more easily dismissed as eccentric geeks of the sort that Silicon Valley is supposed to produce. Now, not only do their products have much greater market saturation, but people are more aware of a) the often unethical ways the executives and companies comport themselves b) the other adverse impacts of AI that have already arrived, and c) the physical cost of building these systems, particularly when it comes to data centers. Finally, toss in the constant stream of headlines in 2026 about AI models going rogue or potentially upending the world’s infrastructure. [ ](https://www.bloodinthemachine.com/p/with-the-backlash-to-data-centers) [ With the backlash to data centers, Flock and AI glasses, a mass opposition to big tech is underway. Silicon Valley is in denial. ](https://www.bloodinthemachine.com/p/with-the-backlash-to-data-centers) Brian Merchant · Aug 27 [ Read full story ](https://www.bloodinthemachine.com/p/with-the-backlash-to-data-centers) As a result, general sentiment was already overwhelmingly skeptical of AI and its overlords, so the table was pretty well set for someone to come along and say ‘just a reminder, the companies that are building the product that promises to take your job and leave a data center in your neighborhood also think that it might exterminate the human race’ and get a strong reaction from the media and the public. The question is: Should we understand this stuff as hype, strategically fanned to feed already swelling valuations? Is it doom marketing? Genuine cause for alarm that the infrastructure that undergirds modern life is facing a novel threat vector? Or reason to be sincerely worried that AI companies are amassing too much power, and that their products are genuinely dangerous? The answer, I’m afraid, is “yes.” Let me try to untangle all of this a bit, because arguments over how to navigate this moment are extremely heated right now, as they are essentially arguments over how to approach the politics of AI at a moment where there may be a unique opening for action. Those sympathetic to AI alignment concerns and x risk arguments—which increasingly includes a faction on the left who want to shut down AI over safety concerns—argue that people who dismiss AI as all hype have their heads in the sand. Meanwhile, critics of the x-risk narrative—which I might note includes a cadre of investors and tech folks on the right, too—argue that it is hype and can be used to further inflate valuations or for pursuing regulatory capture. The challenge is that many feel that dismissing AI as just hype or purely marketing also diminishes the urgency of taking on the AI industry as the novel and threat to labor, civil society, and the public sphere it is; others that by accepting the industry’s own terms, we imbue it with undue power and enable it. But let’s be clear: Declarations that AI is so powerful it might end the world are a kind of marketing, and anyone who says otherwise is just as off base as those who say that’s all that it is. If you don’t think that these sub-trillion dollar companies have higher-ups who noticed that when their founders talked about super-powerful dangerous AI they got spikes in media interest and phone calls from investors, or that those founders didn’t notice that themselves, and lean into certain narratives to advantage their products, then I don’t know what to tell you. Not all marketing is a Pepsi ad campaign with a celebrity spokesperson. Yet confronting the AI industry should certainly be considered an urgent project. Do I share the x-riskers’ fear that out-of-control, super-intelligent AI agents might end the world? I do not. I’ve read a good deal of AI extinction literature over the last couple of years and I have not come across a credible, step-by-step documentation of how exactly AI might move from self-recursively improving AI to killing every single human on the planet. Most of what I’ve read seems predicated on a sort of reverse Ian Malcolmian logic: Eventually, it becomes smart enough and AI, uh, finds a way (to exterminate humanity). Are the AI companies also overstating and dramatizing what their products can do? Yes, pretty much all the time. They’re in a knife fight for market share and are trying to win customers and government contracts before their investors come knocking. And yet. They have concentrated enormous amounts of compute, have extensive data collection and surveillance capacities, have inserted themselves into the state in numerous capacities, including military kill chains, and they are being run by egomaniacal billionaires who are rushing to monopolize an entire new market. The way I think about their most recent frightening-seeming exploits is not as a “swarm of rogue AI agents building a new civilization” or whatever, but as corporations with a hitherto-unimaginable amount of compute at their disposal recklessly experimenting with automation programs, completely unafraid of any repercussions because we have been unwilling or unable to impose any on them. So I think we should welcome any newfound imperative to hold them accountable. I also think that ultimately, the AI critics, Pause AI folks, leftists, doomers, effective altruists, and, honestly, most of the public, want a lot of the same things: legitimate checks and limits on AI companies’ power, actual transparency into what the companies are doing, and for more of AI to be under public control. (Ultimately, a lot of what animates the x-risk fears are rooted in just that: a fear of losing control.) How we move towards all this, exactly, is the question of the day, and while there’s much to be argued over in terms of building a viable political platform to challenge the AI industry’s power, I do want to cast a vote against one particular approach. Not to pick on Chris here, as there are a lot of folks out there proposing stuff like this, and the policy ideas actually stem from AI safety groups. But not only would this be challenging to land politically (I can already hear the ‘China will beat us to AGI’ calls) and all but unworkable in practice, this approach is a) far too limiting, b) fails to address the current harms caused by AI and c) would likely only wind up serving Anthropic and OpenAI; it’s what regulatory capture looks like in action. Full model transparency is the floor for what should be on offer here. If these companies believe their products will kill us, the very least we deserve is to know how. It’s in the public interest. I would also argue we might get a lot of the way to stopping any currently envisioned robot apocalypse simply by forcing AI companies to assume liability, and to submit to the full brunt of the law. If Sam Altman were liable to be charged with a felony for approving the hack on Hugging Face1, if Google was forced to pay defamation fines each time it published a false and injurious AI Overviews, these companies might suddenly find cause to restrain their models’ output, and we might hear less about rogue AI. We would need to introduce new frameworks and available tools for tracking automated lawbreaking, to be sure, but I’d wager that little would frighten the AI companies more than actually being held accountable for what their products enable. To that end, Illinois has passed an AI liability law, which the industry fought tooth and nail, and Florida is considering one. The next steps would be towards moving AI under public control; again, it’s only reasonable, since everyone, not just AI insiders, should get a say over how a technology whose developers say might kill us is developed and deployed. Dismantling the whole industrial project as currently structured should be on the table, too, pending democratic input. But that’s for another post. For now, suffice to say that while I won’t be losing any sleep about an AI-enabled extinction event, Mr. Coxon and co. have given us an opportunity to underscore the urgency of the clear and present damage AI companies are doing, the extreme power they wield and the extent to which they hold themselves unaccountable, and the abundance of political capital there is out there for taking them on. Subscribe 1 Purely speculative! I do not know if he did or not.

Sep 12 • 3:59 AM EDT • Politics • bloodinthemachine.com

Can CVS Health (CVS) Still Look Cheap After A 50% Run?

CVS Health has delivered a strong 49.8% gain over the past three years, yet its valuation checks still point to a stock that looks cheap on broad measures rather than fully priced in after the run. The 49.8% share price gain over three years suggests investors have already rewarded CVS Health for progress in the business, so the question is how much upside is left from here. Recent bullish analyst commentary that highlights recovery at Aetna and the potential return of share buybacks can...

Sep 12 • 3:25 AM EDT • Health • simplywall.st

Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know

A number of stocks jumped in the morning session after Morningstar reported that challenging macroeconomic conditions across broader equity markets drove a rotation into healthcare, lifting the sector index by approximately 7% quarter-to-date to reach a 5% valuation premium.

Sep 12 • 12:35 AM EDT • Health • finance.yahoo.com

AI startup Discovery Loop seeks around $50 billion valuation, Business Insider reports

AI startup Discovery Loop is seeking to raise funds again ​at a valuation of $50 billion, ‌the Business Insider reported on Friday, citing people familiar with the matter.

Sep 11 • 7:23 PM EDT • Business • reuters.com

Jeff Dean's startup Discovery Loop is eyeing a $50 billion valuation

Jeff Dean, former Google chief scientist, is raising another round of funding at a valuation of around $50 billion.

Sep 11 • 6:42 PM EDT • Business • businessinsider.com

India's NSE CEO says other business growth could curb weekly options' revenue share

National Stock Exchange of ​India's chief said ‌on Friday that growth in its other businesses ​is likely to ​reduce the share of ⁠revenue generated ​by weekly options trading, ​as the country's largest bourse seeks a valuation of up ​to 4.42 ​trillion rupees ($46.26 billion) through its ‌long-awaited ⁠IPO.

Sep 11 • 8:03 AM EDT • Business • reuters.com

New economic tool helps planners consider urban public health impacts

Senior urban development decision-makers have revealed there is currently little incentive to consider public health impacts when shaping towns and cities, according to a new study that highlights the potential of an innovative economic valuation tool to address the problem.

Sep 10 • 12:28 PM EDT • Health • news-medical.net

PE Daily: Agora Strikes First Deal With Vheda Health Investment

Plus, Peter Thiel-backed AI startup Cognition’s valuation nearly doubles to $48 billion in a $2 billion round led by Andreessen Horowitz and Accel.

Sep 10 • 7:34 AM EDT • Health • wsj.com

Fabiani Outlines Lazio’s Strategy, Squad Valuation, & Fan Relations

During the official press conference presentation of new signing Diogo Leite at Formello, Lazio Sporting Director Angelo Fabiani addressed the media on several pressing topics surrounding the club.Spe...

Sep 10 • 1:05 AM EDT • Sports • sports.yahoo.com

Flutter Entertainment (FLUT) Faces A Valuation Test As Prediction Markets Draw NFL Attention

Flutter Entertainment (NYSE:FLUT) is stepping into the new NFL season with a fresh source of attention, as prediction markets attract industry focus and are discussed as potential rivals to traditional sports betting volumes. That renewed interest in prediction markets is arriving at a fragile moment for Flutter Entertainment’s share price. The stock trades at US$100.70 after a 7 day share price return of 3.81% and a 30 day share price return of 6.29%. However, it sits well below earlier...

Sep 9 • 1:24 PM EDT • Entertainment • simplywall.st

Science Applications International (SAIC) On Raised 2027 Guidance And Whether The Valuation Is Priced In

Why Science Applications International just moved into focus Science Applications International (SAIC) has landed on investor radars after reporting second quarter and six month results with higher sales and earnings guidance raised for fiscal 2027, shifting expectations for the business. Against that backdrop, Science Applications International has been in a steady uptrend, with the share price returning 26.01% year to date and 11.66% over the past 90 days. The 1 year total shareholder...

Sep 9 • 9:19 AM EDT • Science • simplywall.st

Boston Celtics Get Interesting Evaluation Ahead of Training Camp

With about three weeks to go until training camp begins, ESPN sees the Celtics in a more favorable light than we do.

Sep 9 • 9:15 AM EDT • Sports • sports.yahoo.com

CNBC's Official NFL Team Valuations 2026: Here's how the 32 franchises stack up

The average National Football League team is now worth $10.36 billion, up 35% from a year ago.

Sep 9 • 6:00 AM EDT • Sports • cnbc.com

Sphere Entertainment (SPHR) Expands 4D Wizard Of Oz As Valuation Hinges On Growth Story

New 4D effects spotlight Sphere Entertainment’s product ambitions Sphere Entertainment (SPHR) just rolled out an expanded 4D package for The Wizard of Oz at Sphere, adding animatronic Winged Monkeys, themed scents, Glinda Glitter, pyrotechnic fireworks, and scented apples from September 25, 2026. For investors watching Sphere Entertainment, the latest 4D upgrade lands after a choppy few months, with the share price down about 11% over 30 days but still showing strong momentum through a 51%...

Sep 9 • 3:21 AM EDT • Entertainment • simplywall.st

Luke Fickell Updates Badgers' O-Line Health, Evaluates Week 1 Performance

Wisconsin's head coach provided health updates and an evaluation of his offensive front.

Sep 8 • 2:36 PM EDT • Health • si.com

Mistral raises €3B as sovereign AI becomes big business

The French AI lab has raised €3 billion at a €21 billion valuation in a Series D round led by Samsung, Scaleup Europe and PSG Equity.

Sep 8 • 10:17 AM EDT • Business • techcrunch.com

Has Tencent Music Entertainment Group (NYSE:TME) Fallen Below Fair Value?

Tencent Music Entertainment Group has seen its share price fall sharply over the past year, yet both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and traditional earnings multiples currently point to the stock trading below those valuation checks. The disconnect between a weak recent share performance and signals of potential undervaluation is drawing attention to what the current price really implies about the business. Over the past 12 months the stock has...

Sep 8 • 8:23 AM EDT • Entertainment • simplywall.st

Bi-Polar Performance Arcs Make Evaluation Difficult

It’s not just the A’s. Following his historic 60 HR season in 2025, who in their right mind would have predicted that Cal Raleigh would spend the first half of the 2026 batting .169/.271/.310? That same Raleigh appears to have shaken off the demons and is back to homering at his 2025 pace lately, with […]

Sep 7 • 12:17 PM EDT • Sports • sports.yahoo.com

Commission to present long-awaited Innovation Act proposal

The European Commission will present its proposal for an EU Innovation Act on September 9, with a focus on strengthening public procurement as a driver of innovation and facilitating the use of intellectual property (IP) to secure financing.The proposal was initially meant to be published in March. No explanation has been given for the delay, but it may be linked to issues with the associated impact assessment.The Commission’s Regulatory Scrutiny Board issued a negative opinion on the draft impact assessment following its meeting on January 28, and again on February 27, according to a draft of the Innovation Act published by Agence Europe.In it, the Commission lays out the steps it has taken to address the board’s concerns, including avoiding overlap with the upcoming revision of the EU Public Procurement Directives and removing a mandatory target for EU member states to increase overall innovation procurement spending.The Innovation Act, which was included in last year’s start-up and scale-up strategy, is meant to reduce barriers to bringing innovative solutions to the market and speed up the path from research to commercialisation.Central to the initiative, according to the draft proposal, is the introduction of a harmonised EU framework for the procurement of R&D services by public buyers, including pre-commercial procurement. The plans would also introduce an EU preference in public R&D procurement.“Other leading economies in the world are investing five to eight times more in public procurement of R&D than the EU,” it notes. In Europe, the lack of harmonised rules has led to divergent practices across the bloc, legal uncertainty and limited use of joint, cross-border R&D procurement, it says.Related articlesCommission postpones European Innovation ActParliament draft report adds EU Inc safeguards to prevent fraud and regime shoppingThe text highlights a lack of clarity around the valuation and monetisation of IP as another barrier to the commercialisation of research results. Currently in the EU, IP is rarely used as collateral in financing, which restricts the growth potential of innovative firms. A key reason for this, according to the Commission, is the absence of a harmonised methodology for valuing IP.To address this issue, it plans to introduce an EU-wide IP valuation framework, a digital marketplace for commercialising IP, and a competence centre to help innovators access IP-backed finance.The issue was highlighted by a recent report by the European Union Intellectual Property Office, which referred to developing a “functional market for IP-backed finance” as a “core competitiveness imperative for the next decade,” and key to ensuring capital unlocked by other EU initiatives reaches innovative firms.The Innovation Act is one of several ways the Commission hopes to reduce fragmentation in the single market and help innovative companies to scale in Europe, complementing other initiatives such as the EU-wide corporate regime, dubbed EU Inc.The leaked draft is not the final version that will be published on September 9, according to a Commission official.

Sep 7 • 8:00 AM EDT • Science • sciencebusiness.net

Opinion: Revaluation delay sacrifices businesses without fixing Hartford’s finances

Hartford Mayor Arunan Arulampalam wants to delay the city’s property revaluation as shifting home and office values threaten its financial stability.

Sep 7 • 4:00 AM EDT • Business • hartfordbusiness.com

Blazers' Front Office Ranked Third-Worst in NBA

New ownership turmoil, brain drain in the scouting department, and a questionable blockbuster trade for Ja Morant spark a freefall for Portland in the latest league-wide evaluations.

Sep 6 • 1:29 PM EDT • Sports • sports.yahoo.com

CVS Health (CVS) Stock Looks Below Fair Value But Mixed After 65% Return

CVS Health stock has delivered a strong 64.8% return over the past three years, and the current valuation picture is not a clear bargain or a clear stretch. Recent gains sit alongside a mixed value score and fresh headlines around its health insurance and compliance record, which give investors a few moving parts to weigh. The 64.8% three year return highlights how much value the market has already credited to CVS Health, so fresh buyers now have to judge whether that past performance still...

Sep 6 • 8:08 AM EDT • Health • finance.yahoo.com

Wonderful is growing like Wiz, but its business is very different

The Israeli AI startup has reached a $5 billion valuation and a $70 million revenue run rate in less than two years, but its economics look far less like those of a traditional software company.

Sep 6 • 2:57 AM EDT • Business • calcalistech.com

LifeStance Health Group (LFST) Following Mental Health Growth Narrative Still Looks Near Fair Value

Recent performance puts LifeStance Health Group in focus LifeStance Health Group (LFST) stock has drawn fresh attention after a strong run over the past month and past 3 months, prompting some investors to revisit how the company’s current valuation aligns with its fundamentals. Zooming out from the recent rally, LifeStance Health Group’s share price return over the past 90 days and year to date has been strong, and the 1 year total shareholder return of 137.06% suggests momentum has been...

Sep 5 • 6:18 PM EDT • Health • simplywall.st

Yankees Get $12 Billion Update After Record-Setting Purchase Agreement

The New York Yankees have reached a new record valuation following a historic sale update from a billionaire NFL owner.

Sep 5 • 7:00 AM EDT • Sports • sports.yahoo.com

Jim Cramer Says “Own It, Don’t Trade It” as CVS Health Gains Momentum

A caller on the September 2 episode of Mad Money noted that CVS Health Corporation (NYSE:CVS) is up 21% this year, sports a 3% dividend, and trades at a 28 valuation compared to its 54 average. Pointing to raised guidance, higher price targets, and a massive capital plan, they asked if it makes sense to […]

Sep 5 • 6:32 AM EDT • Health • finance.yahoo.com

UC Riverside receives grant to evaluate California’s traditional health care practices benefit

A $1.25 million grant to UC Riverside from the California Department of Health Care Services (DHCS) will support a statewide evaluation of California's traditional health care practices (THCP) benefit.

Sep 4 • 11:12 PM EDT • Health • news-medical.net

Grant supports evaluation of California’s traditional health care practices benefit

Project evaluates California’s Medicaid reimbursement for traditional healing

Sep 4 • 2:36 PM EDT • Health • news.ucr.edu

Has Flutter Entertainment (NYSE:FLUT) Fallen Far Enough To Look Cheap?

Flutter Entertainment’s share price has undergone a sharp reset over the past year, yet broader valuation checks still suggest the stock screens as inexpensive. This puts recent price weakness in contrast with a more constructive read from its fundamentals-based metrics. The share price has fallen 65% over the past year, indicating a major reset in investor expectations for Flutter Entertainment. Regulatory clarity around U.S. sports prediction markets, including the New Jersey petition...

Sep 4 • 6:22 AM EDT • Entertainment • simplywall.st

Colorado’s education paradigm déja-vu

Déja-vu for 10 years. In 2015-2016, state standardized testing was fully integrated into teacher performance evaluation. The tests comprised 50% of teacher “performance.” The idea was to follow the General Electric “rank-and-yank” human resources model. At GE, the model went like this: top 20% of employees got raises and bonuses; the middle 70% got to […]

Sep 3 • 2:45 AM EDT • Politics • coloradopolitics.com

New research explores the frequency in which CMS devalues radiology services

“Variation in valuation adjustment rates and amounts may reflect factors such as specialty society influence, valuation methods and negotiation strategies,” experts write in JAMA Network Open.

Sep 2 • 7:34 AM EDT • Business • radiologybusiness.com

Women's health

The European Medicines Agency (EMA) works to ensure that the needs of women are considered throughout the development, evaluation and use of medicines in the European Union (EU). This includes promoting appropriate representation in clinical research, providing guidance to medicine developers, improving knowledge on medicine use during pregnancy and breastfeeding, and generating real world evidence on women's health.

Sep 2 • 4:30 AM EDT • Health • ema.europa.eu

Judge orders mental health evaluation for man accused of threatening to kill governor

The man accused of threatening to kill Washington Governor Bob Ferguson was due in court Monday morning to enter a plea.

Aug 31 • 6:39 PM EDT • Health • katu.com

Judge orders mental health evaluation for man accused of threatening to kill governor

The man accused of threatening to kill Washington Governor Bob Ferguson was due in court Monday morning to enter a plea.

Aug 31 • 6:39 PM EDT • Health • katu.com

Judge orders mental health evaluation for man accused of threatening to kill governor

The man accused of threatening to kill Washington Governor Bob Ferguson was due in court Monday morning to enter a plea.

Aug 31 • 6:39 PM EDT • Health • katu.com

Judge orders mental health evaluation for man accused of threatening to kill governor

The man accused of threatening to kill Washington Governor Bob Ferguson was due in court Monday morning to enter a plea.

Aug 31 • 6:39 PM EDT • Health • komonews.com

Steelers’ Will Howard Undergoes Medical Evaluation After Bills Game: Report

The Pittsburgh Tribune-Review's Chris Adamski reported Pittsburgh Steelers quarterback Will Howard needed evaluation from the medical staff after facing the Buffalo Bills. The post Steelers’ Will Howard Undergoes Medical Evaluation After Bills Game: Report appeared first on HEAVY.

Aug 28 • 2:02 AM EDT • Sports • sports.yahoo.com

Judge orders mental health evaluation for man found with gun at Trump golf course in LA

Judge ruled Jeanine John Taele, discovered with firearm days before Trump visit, was unfit to face felony charge

Aug 27 • 11:32 AM EDT • Health • theguardian.com

Viral AI startup Instinct has raised $350 million at a $2.5 billion valuation

The startup is only a year old but it has already generated a massive amount of hype (and money) while also spurring privacy concerns.

Aug 26 • 8:24 PM EDT • Technology • techcrunch.com

Seoul National University of Science and Technology researchers explore how probabilistic analysis can help improve nuclear safety

Traditional approaches for designing primary coolant pipes in nuclear power plants consider highly unlikely, extreme scenarios. Estimating pipe rupture frequency is a more practical approach. In a new study, researchers investigated the pipe rupture frequency of coolant pipes using a probabilistic framework that accounts for material properties, degradation pathway, and even inspection performance, offering a risk-informed approach to design and evaluation.

Aug 26 • 8:00 PM EDT • Science • eurekalert.org

Bazzell on Unrivaled’s Five Year Plan

Alex Bazzell on Unrivaled's new $650 million valuation and player equity model.

Aug 26 • 3:04 PM EDT • Sports • sports.yahoo.com

Emerald AI reaches unicorn status with $1.05B valuation

Emerald AI announced Tuesday it has raised $150 million in a Series A funding round, vaulting the company to unicorn status.

Aug 26 • 2:30 PM EDT • Business • virginiabusiness.com

VCs Are So Obsessed With This AI Assistant That Its Valuation Jumped Fivefold In Weeks

A hot new AI agent called Instinct was valued at $500 million earlier in August, sources say. Now it's raising a new round at a $2.5 billion valuation from Benchmark and Index.

Aug 26 • 2:10 PM EDT • Technology • forbes.com

Health care worker hospitalized following alleged assault at CT correctional institution

An incarcerated individual allegedly ran toward the worker and struck them in the back of the head following a medical evaluation.

Aug 24 • 9:36 PM EDT • Health • courant.com

Mozambique strengthens regulation of medicines and imported vaccines, boosting health protection

Mozambique has reached a major milestone in strengthening the regulation of medicines and imported vaccines, with its national regulatory authority recognized by the World Health Organization (WHO) as having a stable, well-functioning and integrated regulatory system.The Autoridade Nacional Reguladora de Medicamentos de Moçambique (ANARME) has achieved Maturity Level 3 (ML3) for the regulation of medicines and imported vaccines under WHO’s global classification of national regulatory authorities.Mozambique becomes the 10th country in Africa to reach ML3, joining Egypt, Ethiopia, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania and Zimbabwe and marking further momentum in strengthening regulatory systems across the region.For people in Mozambique, stronger regulation means greater assurance that medicines and vaccines are appropriately evaluated for quality, safety and efficacy and monitored throughout their lifecycle. It also strengthens the country’s ability to identify and respond to safety concerns and substandard or falsified products, while supporting timely access to quality-assured health products.“Mozambique’s achievement is the result of sustained investment in regulatory capacity that will deliver crucial benefits for public health,” said Dr Sylvie Briand, WHO Chief Scientist and Assistant Director-General a.i. for Health Systems, Access and Data. “Strong regulatory systems protect people, build confidence in health products and help countries respond more effectively to evolving public health needs and challenges. Mozambique’s progress also contributes to advancing regulatory capacity across Africa and promoting more equitable access to safe and quality-assured medicines and vaccines.”Building a stronger regulatory systemMozambique’s achievement follows years of sustained efforts to build the institutions and capabilities needed for effective regulation.WHO worked closely with ANARME throughout this process, assessing the national regulatory system and supporting the authority in addressing identified gaps and strengthening priority areas.WHO evaluates national regulatory systems using its Global Benchmarking Tool (GBT), which assesses the regulatory functions required to ensure the quality, safety and efficacy of medical products. These include registration and marketing authorization, licensing, market surveillance and control, pharmacovigilance, regulatory inspection, laboratory testing and oversight of clinical trials, as applicable. WHO’s maturity levels range from 1 to 4. Reaching ML3 confirms a stable, well-functioning and integrated regulatory system, while ML4 represents an advanced system focused on continuous improvement.Benefits for Mozambique and the African continentAn ML3 regulatory system can support more timely and predictable regulatory decisions, reinforce safety monitoring and help ensure that health products entering and remaining on the market meet appropriate standards.It also creates greater opportunities for regulatory cooperation and reliance – approaches that help authorities make use of the work and decisions of trusted regulators, reduce unnecessary duplication and allocate limited resources more efficiently, while maintaining rigorous standards for quality, safety and efficacy.As the first Portuguese-speaking country in Africa to reach ML3, Mozambique’s experience can also contribute to strengthening regulatory systems and fostering greater cooperation, knowledge sharing and reliance among Portuguese-speaking countries and across the African continent. Its achievement further reinforces a more connected African regulatory ecosystem, providing a solid foundation on which the newly established African Medicines Agency can build to advance regulatory convergence and cooperation across the region.Strengthening confidence in regulatory recognitionMozambique’s achievement comes as WHO strengthens the process through which the performance of national regulatory systems is recognized.The newly established Technical Advisory Group on Regulatory Systems Strengthening (TAG-RSS) brings together independent international experts to advise WHO on whether recommendations concerning regulatory authorities reaching ML3 and ML4 and WHO-Listed Authorities, are supported by the findings of WHO evaluation processes. Its recommendations provide an additional level of independent assurance, strengthening the impartiality, transparency and credibility of WHO’s recognition process.Mozambique is among the first countries to achieve ML3 following consideration and recommendation by the TAG-RSS. As part of the same TAG-RSS process, South Africa was recommended to retain its ML3 status for the regulation of vaccines manufactured, imported or distributed in the country, following an additional WHO assessment. This extends the recognition first granted in 2022 and underscores the sustained performance of the South African Health Products Regulatory Authority (SAHPRA).The two recognitions highlight continued progress in strengthening regulatory systems across Africa, as well as the importance of continued performance, improvement and assessment in sustaining regulatory maturity.WHO will continue working with ANARME and SAHPRA to sustain these gains and support continuous improvement as science, technologies and public health needs evolve.

Aug 24 • 8:00 AM EDT • Health • who.int

News | Government enlists business rates expert Jerry Schurder for pubs and hotels review

Review will feed into the 2029 rates revaluation

Aug 23 • 8:00 PM EDT • Business • costar.com

Eastlake science students make district history

Three Eastlake High School students made Sweetwater Union High School District history this year when they became the first students from the district to qualify for the International Science and Engineering Fair, an international competition that brings together some of the top high school researchers from around the world. Ronald Wyatt, Giles Del Priore and Ihan Sung advanced to the competition after successful runs at regional and state science fairs. Sung went a step further, placing fourth in the chemistry category at ISEF. The students were recognized on Aug. 10 during a Sweetwater Union High School District board meeting at the district office in Chula Vista.For Wyatt and Del Priore, recent Eastlake graduates, the journey began with a shared concern about dementia and the challenges faced by families caring for loved ones with memory impairment. Their engineering project, “Design and Evaluation of a Behaviorally Grounded Caregiver-Governed AI Companion for Individuals with Memory Impairment,” earned the Sweepstakes Award at the Sweetwater District STEM Fair and first place in its division at the Greater San Diego Science and Engineering Fair. The project explored whether Artificial Intelligence could provide companionship and support while helping reduce stress for people with dementia and their caregivers. “Our inspiration came from personal experience. Both of us have seen family members and loved ones affected by dementia, and we’ve witnessed how overwhelming the caregiving process can be,” Wyatt said. Del Priore said the students also wanted to address the high cost of third-party health care services while creating something that could potentially help their own families as well as people elsewhere. The students developed an AI system designed with safeguards intended to prevent misinformation reinforcement, emotional escalation and unsafe responses. In 240 controlled trials involving memory, identity, agitation and neutral scenarios, they said the system consistently prevented harmful incorrect reinforcement while using context-aware silence, de-escalation and caregiver verification. The project required the students to combine Artificial Intelligence, psychology, neuroscience and human-computer interaction. For Del Priore, one of the biggest technical challenges was getting the AI companion to communicate verbally with a patient. Hardware limitations required the students to collaborate with multiple Python libraries for speech-to-text and text-to-speech functions while keeping the cost of the companion low. “For us, the biggest challenge was translating complex behavioral and cognitive care principles into a functioning AI system,” Wyatt said.Qualifying for ISEF was a milestone that student expected. The international competition proved to be another milestone. “Competing at ISEF was an incredible experience and unlike anything we’ve ever done before,” Del Priore said. “Being surrounded by some of the most talented young researchers from around the world was both inspiring and motivating.” He said the experience stood out because of the emphasis on collaboration, innovation and scientific discovery. “The most memorable part was seeing how people from completely different backgrounds and disciplines approached solving real-world problems with creativity and passion,” he said. The students also credited teachers and mentors who supported their work. Del Priore said his sophomore-year AP Physics teacher, Dr. Price, was particularly influential. “Through all of my personal and academic struggles, Dr. Price always believed in me,” Del Priore said. “All of his faith in me really molded me into the person I am today and helped create my love for science even through tough times.” Wyatt is continuing his education at UC Santa Cruz, where he plans to study biomolecular engineering and bioinformatics, with an interest in research involving Artificial Intelligence, biology and health care. Del Priore plans to double major in chemistry and accounting. Sung, a rising Eastlake senior, qualified for ISEF after winning first place in the Engineering: Energy, Materials & Transport category at the Greater San Diego Science and Engineering Fair and first place in chemistry at the California Science and Engineering Fair. His project, “Renewable Ammonia Electrochemical Synthesis by Glow Discharge with an Iron-Based Catalyst,” involved a device he designed and engineered to produce renewable ammonia, with potential applications in fertilizer production and energy storage. Sung became interested in the project after considering the relationship between food insecurity and fertilizer costs. His system uses plasma to break apart nitrogen molecules so they can interact with hydrogen and form ammonia. At ISEF, Sung competed against more than 1,700 students from 65 countries and earned fourth place in chemistry. “I am proud to become one of te first students in the district to qualify for ISEF because this milestone can inspire others in the district to attain similar goals,” Sung said.

Aug 23 • 1:00 PM EDT • Science • thestarnews.com

OpenAI Is Adding Business Users Faster Than Anthropic. That May Matter More Than Valuation

New data shows the ChatGPT maker outpacing Anthropic among business customers, even as its rival remains the revenue leader.

Aug 22 • 9:20 PM EDT • Business • inc.com

WEBTOON Entertainment (WBTN) Faces A Valuation Test After Weak Results And Modest Outlook

WEBTOON Entertainment (WBTN) shares are reacting after the company reported second quarter 2026 results, which showed lower sales and a wider net loss, along with third quarter guidance that points to modest constant currency revenue growth. See our latest analysis for WEBTOON Entertainment. WEBTOON Entertainment’s recent update comes after a weak run for holders, with the share price down 33.38% year to date and the 1 year total shareholder return declining 42.03%. However, the 1 day and 7...

Aug 22 • 7:19 AM EDT • Entertainment • simplywall.st

Amazon's AI Business Passed a $25 Billion Run Rate. Where Does That Put the Stock in 5 Years?

One of the fastest-growing businesses inside the company more than doubled over the past year. What does five more years of that do to a $2.8 trillion valuation?

Aug 19 • 7:08 AM EDT • Business • fool.com

Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling

The study, Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder (TAB), is a double-blind, randomized, placebo-controlled trial conducted through the National Institute on Drug Abuse’s Clinical Trials Network.

Aug 18 • 10:56 AM EDT • Health • news.vumc.org

SpaceX shares are 'crazy overvalued,' says Scott Galloway

Galloway argued that SpaceX's huge valuation was driven partly by unusually favorable market mechanics at its IPO in June.

Aug 18 • 8:32 AM EDT • Business • businessinsider.com

How rich do you need to be to buy a professional sports team?

Aug 17 • 3:19 PM EDT • Technology • sports.yahoo.com

Trump administration pauses border construction project in Big Bend National Park

The Trump administration says it is temporarily pausing construction of a controversial border construction project in the Big Bend National Park while the head of the agency tasked with building the wall visits Texas to do an “on-the-ground evaluation.”

Aug 17 • 2:56 PM EDT • Politics • pbs.org

Why Similar Consumer Businesses Sell For Very Different Prices

Consumer business valuation depends on more than EBITDA. See why similar earnings can produce different prices and what buyers examine before making an offer.

Aug 17 • 9:33 AM EDT • Business • forbes.com

Can Oscar Health (OSCR) Still Look Cheap After Strong Q2?

Oscar Health stock has delivered a very large 3 year return while the broader valuation checks still lean cautious, with a low value score hinting that the recent re rating may not be a simple bargain story. Oscar Health has returned about 3.6x over the past 3 years, which puts a spotlight on whether recent enthusiasm already prices in much of the progress. Recent profitability and revenue growth can support investor expectations for the business, while concerns around medical cost trends...

Aug 15 • 2:09 PM EDT • Health • finance.yahoo.com

Sports Team Sale Prices Keep Hitting New Highs

This week’s deal for the Los Angeles Lakers, which valued the team at a record $12.5 billion, was the latest in a pattern of skyrocketing prices.

Aug 15 • 5:02 AM EDT • Business • nytimes.com

Sports Team Sale Prices Keep Hitting New Highs

This week’s deal for the Los Angeles Lakers, which valued the team at a record $12.5 billion, was the latest in a pattern of skyrocketing prices.

Aug 15 • 5:02 AM EDT • Sports • nytimes.com

Anthropic IPO valuation hinges on $190-200 billion 2028 revenue forecast, sources say

As Anthropic prepares for what could be one of the biggest IPOs on record, Wall Street is looking further into the future than it commonly does to put a price on ​the AI company, valuing it based on how much revenue it could generate two years from now.

Aug 14 • 8:12 PM EDT • Business • reuters.com

New Listen Up Florida campaign warns of hearing loss risks

Florida launches the Listen Up Florida campaign to encourage hearing loss prevention and regular evaluations.

Aug 14 • 10:03 AM EDT • Health • wftv.com

Gary Vaynerchuk on the rise of alternative sports, surging sports team valuations

Gary Vaynerchuk, VaynerMedia CEO and VaynerX chairman, joins 'Squawk Box' to discuss the rise of alternative sports, surging sports team valuations, and more.

Aug 14 • 8:29 AM EDT • Sports • cnbc.com

5 Core Principles To Master Before You Sell Your Business

Learn the five core principles that determine whether your business is truly sellable, from owner independence to knowing your real valuation number.

Aug 14 • 8:03 AM EDT • Business • forbes.com

Anthropic’s $2 trillion problem: Its underlying business is nowhere near the IPO valuation it wants

Everything you need to know before you reach the office this morning.

Aug 14 • 6:27 AM EDT • Business • fortune.com

Madison Square Garden Entertainment (MSGE) Following Earnings Beat Faces A Fuller Valuation Debate

Madison Square Garden Entertainment (MSGE) drew fresh investor attention after reporting fourth quarter and full year 2026 results that exceeded consensus estimates on revenue and earnings, supported by strong live events and food and beverage sales. See our latest analysis for Madison Square Garden Entertainment. The upbeat results have come alongside a sharp share price move, with Madison Square Garden Entertainment’s 1-day share price return of 11.40% and 30-day share price return of...

Aug 13 • 2:16 PM EDT • Entertainment • finance.yahoo.com

MSG's concert business had a really good year, says Ariel Investments' Charles Bobrinskoy

Charles Bobrinskoy, Ariel Investments vice chairman, joins 'The Exchange' to discuss stocks in the sport sector, their valuations and much more.

Aug 13 • 1:35 PM EDT • Business • cnbc.com

Madison Square Garden Entertainment (MSGE) Stock May Be Fully Priced After Record Revenue

Madison Square Garden Entertainment has delivered a very strong share price run over the past three years, while the latest valuation checks suggest the stock now leans expensive rather than like an obvious bargain. The stock has returned 186.8% over the past three years, which puts recent buyers in a very different position to investors who entered earlier in the move. Recent record revenue and higher event activity can support expectations for healthier earnings, while any setback in...

Aug 13 • 9:13 AM EDT • Entertainment • finance.yahoo.com

Former OpenAI product chief is raising $150 million for a new AI science startup

Kevin Weil is seeking a valuation of at least $750 million for the new venture, which is focused on gathering scientific data for AI models

Aug 12 • 9:59 AM EDT • Science • qz.com

Crimson Desert dev comments on status of Nintendo Switch 2 port, targeting first half of 2027

Pearl Abyss has commented again on the Nintendo Switch 2 port of Crimson Desert, providing the most encouraging update we’ve had thus far. In its latest earnings letter, the company said that it’s now “currently playable at a foundational level, and technical evaluations are underway to ensure performance optimization and compliance with our quality standards.” The other piece of important...

Aug 11 • 6:40 PM EDT • Technology • nintendoeverything.com

AI science evaluation tools should be scrutinized through ‘critically engaged pragmatism’

Creators of AI tools need to be transparent about how they are designed, trained, and benchmarked to facilitate assessments of their purpose-specific reliability, liability to different kinds of er…

Aug 11 • 2:53 PM EDT • Science • cip.uw.edu

Gates Foundation gives $540 million to UW health institute, the largest gift in university history

The Gates Foundation is giving $540.2 million over 10 years to the University of Washington's Institute for Health Metrics and Evaluation, the largest charitable gift in UW history. The grant will expand the institute's Global Burden of Disease study and comes as global health funding falls sharply.

Aug 10 • 11:50 AM EDT • Health • geekwire.com

No-Reserve 1977 Pontiac Firebird Trans Am Brings Bandit Style With a 400 V8 and Four-Speed

A no-reserve 1977 Pontiac Firebird Trans Am with a 400 V8, four-speed manual, and Bandit-style black-and-gold graphics is up for bid on Hagerty Marketplace, with Hagerty's valuation tools offering a window into what this second-generation Firebird is really worth.

Aug 10 • 11:00 AM EDT • Technology • autos.yahoo.com

UNCW Business School Students Travel to Prague for Real-Life Consulting Experience by David Glew

This article was contributed by Kestrel Smoot, International Programs Coordinator for UNCW’s Cameron School of Business. During the most recent spring semester, 33 upper-level finance and marketing students from the UNCW’s Cameron School of Business traveled to Prague, Czechia, to participate in an intensive international consulting project. Unlike traditional study-abroad programs, the Prague consultancy project focuses on real client engagement. Each year’s project is entirely new, designed through collaboration between faculty and industry partners to identify a current business challenge that students will address. This year, students worked with MAMS-Champi, a Czech non-alcoholic beverage company that is seeking to expand into other global markets. Throughout the first half of the semester, students attend class at UNCW and prepare for their time abroad by conducting preliminary research, developing analytical frameworks, and organizing themselves into specialized teams responsible for tasks such as marketing strategy, industry analysis, consumer segmentation, and competitive evaluation. The course emphasizes independence and teamwork, requiring students to take ownership of their work, manage deadlines, and collaborate across functional groups. Additionally, faculty serve as advisors, allowing students to navigate the complexities of the project much as they would in a professional consulting environment. Once in Prague, students met with company leadership, toured facilities, and refined their recommendations based on real-time feedback. The in-person component is widely regarded as the most transformative aspect of the program because students must synthesize weeks of work into a cohesive presentation and deliver it to the client, demonstrating professionalism, strategic thinking, and adaptability. Beyond the consulting work, students participated in cultural and educational activities that broadened their understanding of global business environments. They explored Prague’s historic districts, learned about Czech culture, and engaged with local professionals. These experiences helped students understand how economic, regulatory, and social factors shape market opportunities. The Prague consultancy project stands as a defining example of the Cameron School of Business’s commitment to experiential learning, consistently strengthening students’ confidence, enhancing their resumes, and serving as a focal point in job interviews. Employers recognize the value of the hands-on experience and transferable skills students gain, underscoring the program’s role in preparing industry-ready graduates for today’s fast-moving business landscape.

Aug 10 • 8:00 AM EDT • Business • wilmingtonbiz.com

Gates Foundation to give historic $540 million to UW health institute

The Gates Foundation is donating over half a billion dollars to UW's Institute of Health Metrics and Evaluation, whose research informs policies around the world.

Aug 10 • 8:00 AM EDT • Health • seattletimes.com

Starz Entertainment (STRZ) Stock Sees Fair Value Lift After Q1 Analyst Revisions

Price targets for Starz Entertainment have been refreshed, with Fair Value moving from US$28.50 to about US$32.33, which marks a higher central valuation estimate in current models. These updates sit alongside Street commentary that weighs the separation from Lionsgate, Q1 model changes, and the new content approach, as analysts balance upside from execution against risks and the recent share price move. Read on to see how to track these shifting views and follow the evolving narrative around...

Aug 10 • 5:09 AM EDT • Entertainment • finance.yahoo.com

Hackensack Meridian Health Becomes First Health System to Earn Responsible Use of AI in Healthcare Certification from Joint Commission

The organization has implemented a formal AI governance structure emphasizing safety, privacy, and ongoing evaluation

Aug 9 • 8:00 PM EDT • Health • hcinnovationgroup.com

Here’s how a summertime health plan review can pay off during fall open enrollment

Learn key timelines, evaluation tips, and important documents to prepare for health insurance enrollment to avoid coverage gaps in 2027.

Aug 9 • 1:00 AM EDT • Health • nola.com

The Best Time To Sell Your Business Is When You Don’t Need To

The best time to sell your business is when you don't need to. Learn why early exit planning gives owners more leverage, stronger valuations and greater freedom.

Aug 7 • 5:00 AM EDT • Business • forbes.com

A clinically validated framework for auditing AI chatbot behavior in mental health interactions

Nature Medicine - Across 810 conversations, an evaluation framework finds that AI chatbots often amplify simulated users’ psychological vulnerabilities, revealing persistent safety risks in...

Aug 6 • 8:00 PM EDT • Health • nature.com

OpenAI reported 2 more incidents of rogue AI agents

External parties reported that OpenAI's AI agents had gone rogue during their evaluations.

Aug 5 • 2:13 AM EDT • Business • businessinsider.com

Motion filed Tuesday seeks mental health evaluation in Ohio child endangering case

Attorneys for Elizabeth Siders have filed a motion asking a judge to order a mental health evaluation to determine whether she is competent to stand trial.

Aug 4 • 5:23 PM EDT • Health • komonews.com

Steps announced to improve public safety in Chippewa Entertainment District

In a Tuesday press conference at Buffalo City Hall, Mayor Sean Ryan was joined by fellow city and business leaders to announce the next phase of his administration’s efforts to improve public safety in the Chippewa Entertainment District after several weeks of enhanced enforcement and evaluation. Read more from WBEN: | WBEN

Aug 4 • 2:34 PM EDT • Entertainment • audacy.com

MrBeast Sales Slow, Angel Stock Falls, MUBI and Neon Look for Hits, and Will an NBA Franchise Set a Sales Record?

(Welcome to the Entertainment Strategy Guy, a newsletter on the entertainment industry and business strategy. I write a weekly Streaming Ratings Report and a bi-weekly strategy column, along with occasional deep dives into other topics, like today’s article. Please subscribe.) You probably remember egg prices spiking a few years ago. This led to a lot of debate between the pro-market/pro-competition/antitrust/Neo-Brandesian crowd and the center/center-right/center-left/abundance/libertarian crowd over the cause, whether it was the avian flu outbreak or whether industry consolidation led to price fixing, using avian flu as a convenient cover. Basel Musharbash wrote a whole investigation at BIG looking at it. Well, two years later, we have our answer: it was price fixing. The Justice Department found proof, via emails, of price fixing. Indeed, just the threat of an investigation brought prices down two years ago: I bring this up because at least half a dozen of my favorite political writers and pundits, who were skeptical about price fixing at the time, haven’t written any mea culpas on this issue. It’s really dispiriting and makes it much, much harder to trust their work on other issues. If you take a hard stand on an issue, then you get it wrong, you need to explain how and why you got it wrong. Or update your priors. This is how epistemological bubbles are formed! All of which is to say, it’s time for another installment of “What I Got Right, What I Got Wrong”. Last issue, I mostly focused on the “wrong” side of the equation, so today’s is a bit more balanced, but with one big mea culpa (though I still stand by my original concerns). Let’s dive right in! Subscribe CORRECTION: UFC Didn’t Release Subscriber Data (But Seems to Have Bragged About It Internally) In my analysis of the viewership of UFC Freedom 250, I wrote... “Paramount has also released datecdotes bragging about their subscriber numbers. Earlier this year, they claimed that the first UFC fight on Paramount+ brought in 1 million subscribers.” Well, that datecdote did not come from a PR rep, but from great reporting from James Faris at Business Insider. The actual quote was this: “Paramount’s flagship streaming service generated about a million new subscribers on the day of its first-ever UFC event, Paramount product chief Dane Glasgow told employees in a town hall on Tuesday morning, three staffers who attended the meeting told Business Insider.“ This wasn’t the biggest goof in the world; even Faris emphasized to me that this is more a “clarification” than a correction. Still, it sounds like, internally, the folks at Paramount were very happy about this result—and I’m guessing they were happy with this news getting out—even though the gains didn’t last through the quarter, dropping to 700K adds. RIGHT: MrBeast’s Struggles Continue... I’m very skeptical about MrBeast’s burgeoning media “empire” and, in particular, its $5 billion valuation, as I wrote earlier this year and last year. Sure enough, according to Business Insider, regarding its “booming” consumer products division_:_ “US sales volume grew 13% year-over-year in 2025, following a 33% leap the previous year, according to a presentation deck dated May 2026....A February 2025 investor deck viewed by Business Insider showed Feastables’ net revenue more than doubled in 2024 from 2023, to $215 million, and was forecast to grow 74% in 2025, to $375 million.” [Emphasis mine.] If you told investors that you projected 74% growth but delivered 13%,1 that’s not ideal. But it’s not just MrBeast. Logan Paul and KSI’s Prime had sales drop in half for their energy drinks. It’s one thing to build a successful entertainment company and an entirely different thing to succeed in the heavily-consolidated-but-also-very-competitive consumer packaged goods space! CPGs are dominated by a few firms with very wide moats compared to YouTube, which has few barriers to entry. These businesses require different skill sets and have completely different business environments. WRONG: Does the NBA Have an $8 Billion Bidder? Almost as soon as I published my article about the NBA’s finances, casting skepticism on NBA expansion, I saw this Front Office Sports headline: One group “claims to have already raised $8 billion” for the Vegas expansion team. I mean, wow. That’s just $2 billion less than what the Los Angeles Lakers were valued at when they were sold just last year. And they’re arguably the most popular team in the NBA. (Side note: the new owner is now under an investigation for fraud in how he went about financing the Lakers and the Dodgers purchases.) So much for the “dried up” language I used in that article. (This is why I usually stick to my “Entertainment Nuance Guy” tone in articles...) I went off old information—from April, when I read/heard about the NBA downplaying expansion efforts—instead of doing a quick double-check for new news. That said...if you read the article, the market for Seattle is “slow”, with just one reported bidder. So I wasn’t entirely off. This goof has annoyed me since I first published it, mainly because it undercut that article’s real point, which I stand by: NBA franchises are really overvalued right now. Now, I get why NBA teams are overvalued. When it comes to owning sports teams, it’s basically never wrong to assume that some rich person somewhere will care more about owning a team (or just being part of a group since they’re so expensive) than the actual financials. There are only so many teams to own, and opportunities to buy in preferred markets don’t come along very often. This explains why the teams sell for such high multiples (usually above a 10 to 12.5 revenue multiple, which is very high). You only need one person to overpay! Beyond the ultra-wealthy luxury good explanation, I worry NBA teams are becoming speculative assets. More and more private equity investors are buying into NBA teams. But the value, in owning a team, comes from selling it later, not any meaningful relationship to revenue or profit growth. In other words, the newer NBA owners are increasingly expecting someone later to buy their inflated asset. That’s not sound economics; that’s the “greater fool” theory at work.2 At some point, actually making money has to matter. Especially since revenue growth is now below the growth of the stock market. (And this matters because the NBA doesn’t have easy levers to pull to drastically lower their costs—half of their revenue has to go to players and then you actually have to run a team, including coaching, training, travel, media expenses, and more—or raise revenues aside from one-off expansions in America and overseas.) I just don’t see how investors make their money back buying NBA teams, except for selling at a higher price later on down the line. But if revenue/profit growth continues to slow, at some point, someone will be left holding the bag. RIGHT: Baseball and Basketball are about equally popular. Related to the above, I wanted to cite two quick pieces of evidence for one of my other theories: that the NBA and MLB are about as popular as each other, but the NBA gets much, much better media coverage. One YouGov survey has that fans prefer basketball to baseball by 52% to 48%, which I’m guessing is within the margin of error for that poll. That’s virtually even, meaning they’re about the same popularity. Over on NBC, a recent Red Sox-Yankees game averaged 4 million viewers, higher than Sunday Night Basketball’s average of 3.4 million on the same network. A Yankees-Dodgers game averaged 3.9 million two weeks ago. Not every game averages this much, but it shows you that baseball isn’t far off from basketball, depending on the matchup. Altogether, the NBA is just slightly more popular than baseball, but NBC is paying MLB a fraction of what they pay the NBA, a point I’ve made before. RIGHT: Angel, MUBI and Neon Updates... I’ve long been skeptical about many of Hollywood’s buzziest startups/smaller indie studios. It’s not that they don’t make great movies—films like Anora and Everything Everywhere All at Once are amazing—or that they’re not (rightfully) pushing the majors to make better films, but...they get a ton of hype, and that hype often doesn’t live up to the reality or difficulty in scaling up. Starting with MUBI, well, The Wall Street Journal wrote a feature on MUBI’s struggles last April, best summarized by the subheader “After Sequoia valued Mubi at $1 billion, a left-wing revolt sent the indie film company into a tailspin”. MUBI lost $7.3 million on $200 million in revenue in Q4 2025, but reportedly hit a record 1.7 million subscribers at the end of Q1. As for Neon, Department M purchased a “significant stake” in the company earlier this year. How much is that “stake” worth? According to Deadline, “No financial figures for the Neon-Department M deal were disclosed.” So...that’s not great! If it was a big valuation, we’d hear about. Also, I found this curious: “Both Neon and Department M already have separate partnerships with Qatar. The Qatar Film Committee has a slate deal in place with the former, and a biopic production pact with the latter.” Color me skeptical about much Middle Eastern investment dollars. See: LIV Golf. Finally, as for Angel (formerly Angel Studios), their stock very, very slightly popped last month after Young Washington ($20 million budget) which made $45 million in the US, but their stock is still way down from its opening. Smaller Updates RIGHT: The WGA should focus on antitrust concerns! I’ve been on this for years. Post-WGA/AMTPT deal in 2023, I wrote an article for the Ankler calling on the WGA to focus and organize against industry consolidation. Sure enough, the WGA filed a lawsuit against the Paramount-WBD merger, and people are organizing around this issue now. I wish this energy had coalesced earlier (specifically to lobby Washington much earlier), but better late than never! WRONG: Actually, the chip shortage might be due to market manipulation. In my last “Long Reads for the Long Summer” article, I shared an article about how LLMs are causing memory chip prices to spike, which will make all electronics more expensive. Well, turns out, three RAM manufacturers control 90% of the market, and now a private lawsuit accuses them of price-fixing. So yeah. WRONG/UPDATE: The Odyssey will hold! Two weeks ago, I wrote, “As of this moment, we haven’t had a super-blockbuster, though The Odyssey, Spider-Man: Brand New Day and Avengers: Doomsday could all cross the $500 million mark. (At this point, The Odyssey would need a very strong hold to get there.)” Well, it’s safe to say it’s going to have that hold! It only dropped 30% in weekend two and IMAX screenings are sold out all month. Spider-Man: Brand New Day is also off to a great start. RIGHT: People are rushing to get shows out yearly. I’ve long been bullish on yearly, weekly-released shows, and Leslie Goldberg at The Ankler wrote about how many people in town are now listening. WRONG: Mark Carney reverses Canada’s stance on homegrown production. After writing about Canada installing domestic production quotas, Canada has backed off. WRONG: I don’t trust Spider-Man: Brand New Day’s online “views”. When I originally wrote about the latest Spider-Man film’s record-breaking trailer, I thought this was just YouTube views, but after watching this Corridor Crew video and doing more research, well, it’s all social views of the trailer globally. Really? That stat includes TikTok, Reels and YouTube Shorts views. Basically, I don’t trust it anymore. (This film will probably set record, but I trust the pre-sales data more.) RIGHT: Celebrity Production companies are still struggling. I’ve written about this for years, but the company that I didn’t track was Kevin Hart’s HartBeat, which was valued at $650 million but is struggling now and might just end soon, especially after Kevin Hart pulled his endorsement deals. And Bad Robot is moving to NYC. CORRECTION: SpongeBob is a “second run” title. In my 2025 recap article, I had _SpongeBob SquarePants_labelled as a “library” title, when it is still a “second run” show, with new episodes still coming out on Nickelodeon. CORRECTION: In my last “What I Got Right, What I Got Wrong” update, I offered a correction from Doug Creutz and misspelled TD Cowen. Thanks, Grammarly! 1 Though he could have increased prices to make up for the gap, he couldn’t have increased them that much. 2 There’s a theory, which I think that Daryl Morey created and Bill Simmons popularized, that, to be successful building your team, you only need a handful of bad GMs in the league to take advantage of. To be clear, Daryl Morey’s theory was also for signing bad contracts, that you could always get out of bad contracts. Basically, there’s always someone who will make a bad trade. It’s not the same exact thing, but similar enough to the Greater Fool Theory that I really like it.

Aug 4 • 11:55 AM EDT • Entertainment • entertainment.substack.com

Buffalo: Ryan announces steps to improve public safety in Chippewa entertainment district

Mayor Sean Ryan announced the next phase of his administration's efforts to improve public safety in Buffalo's Chippewa entertainment district following several weeks of enhanced enforcement and evaluation.

Aug 4 • 10:05 AM EDT • Entertainment • wnypapers.com

Elizabeth Siders files request for mental health evaluation

The attorney for Elizabeth Siders has asked for her mental health to be evaluated, citing concerns she may not be able to assist in her own defense.

Aug 4 • 9:26 AM EDT • Health • dispatch.com